These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30040972)

  • 1. Effective sustained release of 5-FU-loaded PLGA implant for improving therapeutic index of 5-FU in colon tumor.
    Li L; Li C; Zhou J
    Int J Pharm; 2018 Oct; 550(1-2):380-387. PubMed ID: 30040972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets.
    Leelakanok N; Geary SM; Salem AK
    J Pharm Sci; 2018 Feb; 107(2):690-697. PubMed ID: 29031952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic absorbable gelatin sponge loaded with 5-fluorouracil for treatment of tumors.
    Sun W; Chen Y; Yuan W
    Int J Nanomedicine; 2013; 8():1499-506. PubMed ID: 23626465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
    Li X; Xu Y; Chen G; Wei P; Ping Q
    Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide).
    Wang G; Tucker IG; Roberts MS; Hirst LW
    Pharm Res; 1996 Jul; 13(7):1059-64. PubMed ID: 8842045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of anti-tumor nanoparticle and its inhibition to peritoneal dissemination of colon cancer.
    Tang Q; Wang Y; Huang R; You Q; Wang G; Chen Y; Jiang Z; Liu Z; Yu L; Muhammad S; Wang X
    PLoS One; 2014; 9(6):e98455. PubMed ID: 24896096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil.
    Leelakanok N; Geary S; Salem A
    J Pharm Sci; 2018 Feb; 107(2):513-528. PubMed ID: 29045885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer: Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model.
    Safwat MA; Soliman GM; Sayed D; Attia MA
    Mol Pharm; 2018 Jun; 15(6):2194-2205. PubMed ID: 29701979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats.
    Menei P; Boisdron-Celle M; Croué A; Guy G; Benoit JP
    Neurosurgery; 1996 Jul; 39(1):117-23; discussion 123-4. PubMed ID: 8805147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a 5-fluorouracil-loaded PLGA microsphere delivery system by a solid-in-oil-in-hydrophilic oil (S/O/hO) novel method for the treatment of tumors.
    Lin Q; Cai Y; Yuan M; Ma L; Qiu M; Su J
    Oncol Rep; 2014 Dec; 32(6):2405-10. PubMed ID: 25231485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles.
    Li S; Wang A; Jiang W; Guan Z
    BMC Cancer; 2008 Apr; 8():103. PubMed ID: 18412945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer.
    Bhattacharya S
    Recent Pat Anticancer Drug Discov; 2021; 16(1):84-100. PubMed ID: 33349222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of injectable implants for intratumoral delivery of 5-fluorouracil.
    Chen W; Wu Z; Yang H; Guo S; Li D; Cheng L
    Pharm Dev Technol; 2014 Mar; 19(2):223-31. PubMed ID: 23432601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.
    El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL
    Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral 5-fluorouracil colon-specific delivery through in vivo pellet coating for colon cancer and aberrant crypt foci treatment.
    Bose A; Elyagoby A; Wong TW
    Int J Pharm; 2014 Jul; 468(1-2):178-86. PubMed ID: 24709212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment.
    Anitha A; Deepa N; Chennazhi KP; Lakshmanan VK; Jayakumar R
    Biochim Biophys Acta; 2014 Sep; 1840(9):2730-43. PubMed ID: 24946270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel.
    Yi H; Cho HJ; Cho SM; Lee DG; Abd El-Aty AM; Yoon SJ; Bae GW; Nho K; Kim B; Lee CH; Kim JS; Bartlett MG; Shin HC
    BMC Cancer; 2010 May; 10():211. PubMed ID: 20482808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-encased polymer millirods for sustained release of 5-fluorouracil.
    Qian F; Nasongkla N; Gao J
    J Biomed Mater Res; 2002 Aug; 61(2):203-11. PubMed ID: 12007200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined tumor therapy by using radiofrequency ablation and 5-FU-laden polymer implants: evaluation in rats and rabbits.
    Haaga JR; Exner AA; Wang Y; Stowe NT; Tarcha PJ
    Radiology; 2005 Dec; 237(3):911-8. PubMed ID: 16237145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.